Réau, Valériane
Vallée, Alexandre
Terrier, Benjamin
Plessier, Aurélie
Abisror, Noémie
Ackermann, Félix
Benainous, Ruben
Bohelay, Gérôme
Chabi-Charvillat, Marie-Laure
Cornec, Divi
Desbois, Anne-Claire
Faguer, Stanislas
Freymond, Nathalie
Gaillet, Antoine
Hamidou, Mohamed
Killian, Martin
Le Jeune, Sylvain
Marchetti, Anne
Meyer, Guy
Osorio-Perez, Francisco
Panel, Kewin
Rautou, Pierre-Emmanuel
Rohmer, Julien
Simon, Nicolas
Tcherakian, Colas
Vasse, Marc
Zuelgaray, Elina
Lefevre, Guillaume
Kahn, Jean-Emmanuel
Groh, Matthieu
Article History
Received: 30 November 2020
Accepted: 8 March 2021
First Online: 18 March 2021
Competing interests
: GL: consulting fees from GlaxoSmithKline and AstraZeneca; JEK: consulting fees from GlaxoSmithKline and AstraZeneca; MG: consulting fees from GlaxoSmithKline and AstraZeneca. Other authors have no competing interests.